Effects of cadmium chloride on some mitochondria-related activity and gene expression of human MDA-MB231 breast tumor cells by Cannino, G. et al.
Journal of Inorganic Biochemistry 102 (2008) 1668–1676Contents lists available at ScienceDirect
Journal of Inorganic Biochemistry
journal homepage: www.elsevier .com/locate / j inorgbioEffects of cadmium chloride on some mitochondria-related activity and gene
expression of human MDA-MB231 breast tumor cells
Giuseppe Cannino, Elisa Ferruggia, Claudio Luparello, Anna Maria Rinaldi *
Dipartimento di Biologia Cellulare e dello Sviluppo ‘‘A.Monroy”, Università di Palermo, Viale delle Scienze, ed. 16, 90128 Palermo, Italy
a r t i c l e i n f o a b s t r a c tArticle history:
Received 21 December 2007
Received in revised form 14 April 2008
Accepted 15 April 2008
Available online 22 April 2008
Keywords:
Breast cancer
Cadmium
Mitochondria0162-0134/$ - see front matter  2008 Elsevier Inc. A
doi:10.1016/j.jinorgbio.2008.04.002
* Corresponding author. Fax: +39 0916577430.
E-mail address: rinaldi@unipa.it (A.M. Rinaldi).It was reported that cadmium is able to exert a cytotoxic effect on tumor MDA-MB231 cells, which shows
signs of ‘‘non-classical” apoptosis and is characterized by drastic changes in gene expression pattern. In
this study, we have extended our knowledge of metal-breast cancer cell interactions by analyzing some
mitochondria-related aspects of the stress response to CdCl2 at either 5 or 50 lM 24- or 96-h exposure, by
cytochemical, conventional PCR and Northern/Western blot techniques. We demonstrated that (i) no
modiﬁcation of the mitochondrial mass was detectable due to CdCl2 exposure; (ii) the respiration activity
appeared to be increased after 96-h exposures, while the production of reactive oxygen species was sig-
niﬁcantly induced, as well; (iii) hsp60, hsp70, COXII and COXIV expressions were dependent on the dura-
tion of Cd exposure; (iv) a different hsp60 protein distribution was observed in mitochondrial and post-
mitochondrial extracts and (v) 96-h exposure induced the over-expression of hsc/hsp70 proteins and,
conversely, the down-regulation of cytochrome oxidase subunits II and IV. These observations, in addi-
tion to providing more information on the cellular and molecular aspects of the interaction between
CdCl2 and MDA-MB231 breast tumor cells, contribute to the comprehension of the intracellular molecu-
lar mechanisms implicated in the regulation of some mitochondrial proteins.
 2008 Elsevier Inc. All rights reserved.1. Introduction
Cadmium (Cd), an underground mineral extracted as part of
zinc deposits, is broadly used in the industry (steel, plastics and
batteries) and, as such, it can be considered a wide-spread indus-
trial and environmental pollutant. Food, drinking water and smok-
ing are at present the main sources of daily exposure of humans to
Cd [1, for a review]. It is generally acknowledged that Cd, unlike
other metals (Zn, Se and Mg) is not essential for the human body,
and is not involved in known enzymatic processes or other biolog-
ical activities. On the other hand, due to its chemical similarity to
Zn, Cd may bind with high afﬁnity the Zn-binding domains of sev-
eral metalloproteins, affecting in different ways Zn-dependent cel-
lular functions [2]. A number of recent reports have provided
increasing information on selected aspects of Cd-dependent regu-
lation of gene expression and signal transduction pathways. Cd
ion can enter and accumulate into cells probably through volt-
age-sensitive calcium channels of the plasma membrane [3].
Evidence exists that, at least in some cytotypes, low concentra-
tions of Cd promote DNA synthesis, enhance the expression of sev-
eral classes of genes (e.g. c-fos, c-jun, c-myc, p53, metallothioneins,
glutathione, heat shock proteins, TIF3, TEF-1d, Nur77), and directll rights reserved.intracellular signaling pathways towards up-regulation of cell pro-
liferation, whilst more elevated concentrations are inhibitory and
cytotoxic [4–6]. Even low doses were reported to inhibit prolifera-
tion of human cells in vitro [7]. The mechanisms underlying such
opposite effects are so far poorly understood and, on the other
hand, exposure to Cd appears to evoke cytotype-speciﬁc responses
that involve not only death signalling reactions but also cellular
protective reactions against the toxicity, e.g. by inducing the
expression of stress-response proteins [8].
Cd is classiﬁed in group I of carcinogens by the International
Agency of Research on Cancer [9], being active in both the initia-
tion of cancer, by switching-on oncogenes, and in the progression
of cancer, by increasing the metastatic potential of existing cancer
cells, through mechanisms which are likely to involve multiple fac-
tors, such as interference with E-cadherin function, followed by
disruption of the junctional complexes of epithelial cell sheets
and triggering of b-catenin-mediated activation of oncogenes
[10]. On the other hand, some Authors have produced evidence
on the apoptosis-promoting nature of Cd including its ability to in-
duce DNA fragmentation and chromatin condensation in kidney,
blood and liver cells [11–13]. Although detailed data on the path-
way(s) followed are still missing, Cd-induced apoptosis, at least in
human myeloid leukaemia HL-60 cells, seems to involve cyto-
chrome c release from mitochondria, that, in turn, may cleave
and process caspases thorough the activation of Apaf-1 [14]. In
Table 1
Sequence of primers used for PCR ampliﬁcation
Transcript detected Oligonucleotides (50 ? 30) Predicted product (bp)
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DNA fragmentation, up-regulation of reactive oxygen species and
Bcl-2 over-expression, was described by Zhai et al. [15]. Thus,
although the carcinogenetic property of Cd is well-documented,
in line with such observations, a number of data have appeared
demonstrating the Cd-induced tumor suppression when adminis-
tered at not overtly toxic doses to tumor-cell bearing immune-de-
pleted mice. Cd, in fact, was found to markedly reduce the growth
of MSB sarcoma cells [16], plasmacytoma cells [17], Dunn osteosar-
coma cells [18] and tumorigenic L6 myoblast cells [19]. In addition,
in a liver cancer model system ‘‘in vivo” Cd was reported to induce
tumor-speciﬁc necrosis while preserving the normal surrounding
tissue [20], whilst it was also proven to inhibit growth and progres-
sion of human pulmonary tumor xenografts transplanted into
athymic nude mice [21].
As far as breast cancer is concerned, most available data have
been focused on the effect of metal administration to the estrogens
receptor-positive (ER+) cell line MCF-7, resulting in stimulation of
hsp27 synthesis and impairment of p53 function by phosphoryla-
tion of a serine residue and conformational changes [22]. Notewor-
thy, Garcia-Morales et al. [23] described an oestrogen-mimetic
effect exerted on ER+ MCF-7 cells by Cd, which appeared to be able
to switch-on the transcription of several oestrogen-inducible
genes, like progesterone receptor, cathepsin D and pS2, and to in-
crease cell growth rate; these effects were also observed in vivo
by Johnson et al. [24].
Some of us [25,26] recently produced some preliminary evidence
on the effect of Cd exposure on MDA-MB231 cells, an ER-negative
human mammary carcinoma line, thereby expected to be insensi-
tive to the oestradiol-like modulation by the metal. In light of the
data obtained, we reported that incubation with CdCl2 for different
time lapses did not result in a ‘‘ladder”-like electrophoretic pattern
of extracted DNA, indicative of the occurrence of oligonucleosomal
fragmentation, and that no ‘‘ﬂip-ﬂop” of the phosphatydilserine oc-
curred. Interestingly, CdCl2 appeared to exert substantial effects on
the expression of genes encoding for apoptosis- and stress response
modulators also in this cell line. These results prompted additional
studies on the cellular and molecular aspects of the interaction be-
tween Cd and MDA-MB231 breast tumor cells.
Eukaryotic cells contain a large number of mitochondria
responsible of pyruvate dehydrogenation, Kreb’s cycle, and oxida-
tive phosphorylation, the energy-generating processes coupling
the oxidation of substrates to the synthesis of ATP. In addition,
these organelles are involved in the synthesis of amino acids,
nucleotides, and lipids, in ion homeostasis and in cell proliferation,
motility and programmed death [27–29]. The number, structure,
and functions of mitochondria differ in animal cells and tissues
in relation to the energetic needs [30,31], and in response to phys-
iological or environmental alterations [32–34]. Malfunctioning
mitochondria are related to aging and to many diseases, including
cancer [35–37].
Thus, the present study was designed to obtain information on
Cd-dependent control of mitochondria-related intracellular events
in the MDA-MB231 cell line; in particular, the effect of metal on
mitochondrial mass, respiratory activity, production of reactive
oxygen species (ROS), expression of hsp60, hsc/hsp70 and cyto-
chrome oxidase (COX) subunits II and IV.Hsp60 ATTCCAGCAATGACCATTGC 306
GAGTTAGAACATGCCACCTC
Hsp70 TAACCCCATCATCAGCGGAC 210
GAGCTGAAGCAGAAATGACATAGGA
COXII TTCATGATCACGCCCTCATA 187
TAAAGGATGCGTAGGGATGG
COXIV ATGTTGGCTTCCAGAGCGCTGA 247
CTTCTTCCACTCATTCTTGTCATAG
18S GGACCAGAGGCAAAGCATTTGCC 495
TCAATCTCGGGTGGCTGAACGC2. Materials and methods
2.1. Cell cultures and CdCl2 exposures
The MDA-MB231 breast cancer cell line was routinely grown in
RPMI 1640 medium plus 10% foetal calf serum (Invitrogen, Carls-
bad/CA, USA), 100 U/ml penicillin, 100 lg/ml streptomycin, and2.5 mg/l amphotericin B, at 37 C in a 5% CO2 atmosphere. For
the exposures, the cells were plated in the presence or absence
(as controls) of either 5 or 50 lM CdCl2 (corresponding to 0.56 or
5.6 mg/l of cadmium ions) and grown for either 24- or 96 h, as re-
ported by Luparello et al. [25].
2.2. Cytochemical staining
MDA-MB231 cells were seeded at a concentration of
5  104 cm1 on either coverslips or 6-well dishes and grown with
or without CdCl2.
For the analysis of mitochondrial mass and activity [38], control
and treated cells were incubated with 50 nM MitoTracker Green
and 25 nMMitoTracker Orange in its reduced form CM-H2 TMRos
(both purchased from Molecular Probes/Invitrogen) in fresh
growth medium (RPMI 1640) prewarmed at 37 C for 15 min. in
the dark. In parallel, for the analysis of mitochondrial membrane
potential, control and treated cell preparations were also incubated
with JC-1 (Molecular Probes/Invitrogen, 250 lg/ml ﬁnal dilution in
saline) for 30 min. in the dark. After washings with pre-warmed
medium, cells were observed under an Olympus FV-300 confocal
laser-scanning microscope equipped with Argon (488 nm) and
Helium/Neon (543 nm) lasers with a PlanApo 60  1.40 oil-immer-
sion lens and scanned at 1024  1024 pixel resolution. Ten focal
plans of 100 different microscopic ﬁelds were recorded and images
were analyzed, measured and processed by the ImageJ software for
semi-quantiﬁcation. In selected experiments, cells were incubated
with 15 lM oligomycin (Sigma) for 5 min. before microscopic
observation.
For the analysis of ROS accumulation, control and treated cells
were incubated with 5 mM amino phenyl ﬂuorescein (APF) solu-
tion (Alexis Biochemicals, Lausen, Switzerland; 2 ll/ml ﬁnal dilu-
tion in saline) for 30 min. in the dark [39], then observed under
an Olympus BX50 microscope with 10X objective, equipped with
a Cool-SNAP-Pro Colour digital camera (Media Cybernetics, Silver
Springs/MD, USA) and images were recorded using Image Pro Plus
software (Media Cybernetics). Control images were obtained from
cells treated with 100 lM H2O2. Fifty different microscopic ﬁelds
were recorded and images were analyzed, measured and processed
by the ImageJ software for semi-quantiﬁcation.
2.3. RNA extraction and northern analysis
Isolation of total RNA from monolayers of control and treated
cells was carried out according to Chomczynsky and Sacchi [40].
For the generation of labeled probes, preparations of cDNA from
control MDA-MB231 cells were submitted to PCR in the presence
of primers for hsp60, hsp70, COXII, COXIV or 18S (see Table 1).
The PCR products were resolved in 1.2% agarose gel, the appropri-
ate bands cut and the DNA puriﬁed by GENECLEAN II kit (Q-BIO-
gene, Morgan Inrvine/CA, USA). DNA labeling with [a-32P] dCTP
(speciﬁc activity 10 mCi/ml; GE Healthcare, Little Chalfont, UK)
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Mannheim, Germany). The probes were puriﬁed through Sephadex
G-50 Quick Spin columns (Roche). Northern analyses were per-
formed according to Castiglia et al. [41] with 1  106 cpm/ml of
hybridization solution. The ﬁlters were hybridized with the labeled
probes, then stripped and re-hybridized with 18S probe. Autora-
diographs were scanned and ImageJ software was used to semi-
quantify the relative abundance of mRNAs after normalization
with 18S.
2.4. Preparation of cellular extracts and western analysis
Extracts were prepared as described by Cannino et al. [42,43].
Essentially, pelleted cells were resuspended in homogenization
buffer (HB: 0.32 M sucrose; 50 mM sodium phosphate buffer, pH
6.5; 50 mM KCl; 0.15 mM spermine; 0.15 mM spermidine; 2 mM
EDTA and 0.15 mM EGTA), containing protease inhibitors (2 lg/ml
aprotinin, 2 lg/ml antipain, 2 lg/ml leupeptin, 2 lg/ml pepstatin
A, 1 mM benzamidine and 1 mM phenylmethylsulfonylﬂuoride,
all from Sigma), homogenized at 4 C and centrifuged at 1000g
for 10 min. at 4 C. The supernatant was centrifuged at 12,000g
for 20 min. to obtain a post-mitochondrial (PM) supernatant and
a mitochondrial (M) pellet, which was resuspended in HB. Aliquots
of both fractions were stored in liquid nitrogen until used. Protein
concentration was determined according to Bradford [44] usingFig. 1. Mitochondrial mass and respiratory activity of MDA-MB231 cells. (Top) Represe
treated cells (right) stained with MitoTracker Green (A, C) and MitoTracker Orange (B, D)
(p = 0.268) whilst the exposure for 96-h caused a signiﬁcant increase of respiratory activit
10 focal planes from 100 different ﬁelds observed under the confocal laser-scanning mibovine serum albumin standards at concentrations ranging from
1 to 10 mg/ml.
For the western analyses, 15 lg of either PM or M fractions
were electrophoresized on denaturing 12.5% polyacrylamide slab
gel and blotted onto polyvinylidene ﬂuoride microporous mem-
branes (Immobilon-P, Millipore, USA), in 10 mM 3-cyclohexyl-
amino-1-propanesulfonic acid (CAPS), pH 11.0, containing 10%
methanol, at a constant voltage of 50 V for 30 min at 4 C. Protein
markers (Invitrogen) were run in parallel. After staining with 0.2%
ponceau red in trichloroacetic acid (Sigma) and image acquisition,
the membranes were reacted with the appropriate anti-human pri-
mary antibody, i.e. polyclonal anti–hsp70 (Calbiochem), and
monoclonal antibodies: anti–hsp60 (Sigma), anti–hsc70 (Santa
Cruz), anti-COXII or anti-COXIV (Molecular Probes). The ﬁlters
were then reacted with the AP-conjugated anti-mouse/rabbit sec-
ondary antibody (Promega, 1:7500 dilution) and treated with
NBT-BCIP solution (Sigma). The relative protein amount was calcu-
lated with the ImageJ software and the obtained values normalized
to the total amount of loaded proteins.
2.5. Statistics
The results are presented as mean value ± SD of at least tripli-
cate experiments. The SD is indicated as vertical bars in the ﬁgures.
Data were analyzed using software-assisted Mann Whitney Rankntative ﬂuorescence micrographs of control (left) 5 lM Cd- (centre) and 50 lM Cd-
showing that exposure to metal exerted no signiﬁcant effect on mitochondrial mass
y (*p = 0.006). (Bottom) Histogram displaying the relative pixel intensity of the same
croscope. Bars indicate mean values. Standard deviations are indicated.
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minimal level of statistical signiﬁcance.
3. Results
3.1. Mitochondrial mass and respiratory activity
In a ﬁrst set of experiments, we checked whether the mitochon-
drial mass and respiratory activity of MDA-MB231 tumor cells
were affected by CdCl2 exposure, at the concentrations of 5 and
50 lM for 24-h and 96-h exposures. For this purpose, we incubated
control and treated living cells with MitoTracker Green and Orange
ﬂuorochromes. MitoTrackerTM Green, non-ﬂuorescent in aqueous
solutions, becomes ﬂuorescent only when it accumulates in the
mitochondrial lipid environment, regardless of membrane poten-
tial, thus representing a very useful tool for determining the
mitochondrial mass. MitoTrackerTM Orange CM-H2TMRos,
the non-ﬂuorescent reduced form of tetramethylrosamine is oxi-
dised by the molecular oxygen within actively respiring cells. It
is then sequestered by mitochondria, where it interacts with the
thiol groups of peptides and forms an aldehydic mitochondrion-
selective probe, ﬂuorescent in the red spectrum, thereby allowing
estimating the level of oxidative activity.
In order to calculate the total mitochondrial mass, we inte-
grated the values of pixel intensities for the same 10 focal plans
from 100 different microscopic ﬁelds containing comparable num-
ber of cells. The histograms in Fig. 1 (panels A and C) show that
CdCl2 concentrations and application regimes we applied did notFig. 2. Evaluation of mitochondrial membrane potential. Pixel intensity ratio of JC1 red/gr
values represent the average of 100 different microscopic ﬁelds showing that exposure
potential.
Fig. 3. Production of reactive oxygen species (ROS). (Top) Representative ﬂuorescence m
that only the exposure for 96-h CdCl2 induced a massive accumulation of ROS (
*p < 0.001)
microscopic ﬁelds. The bars indicate the mean values. Standard deviations are indicatedexert signiﬁcant changes of mitochondrial mass. When the same
microscopic ﬁelds (panels B and D) and focal plans were evaluated
for the pixel intensity of MitoTracker Orange, whilst no substantial
changes in the extent of the respiratory activity were recorded
after 24-h exposure, a signiﬁcant increase of respiratory activity
could be observed at long exposure times (96 h).
However, applyingMitoTrackerGreen andOrange staining in the
presence of oligomycin, an ATP synthase-inhibiting antibiotic that
blocks oxidative phosphorylation, oligomycin treatment of control
and Cd-treatedMDA-MB231 cells was found to determine the mas-
sive switching-off of the ﬂuorescent signal of MitoTracker Orange
without affecting that of MitoTracker Green (data not shown).
To detect variations of mitochondrial transmembrane electrical
potential after metal exposure, we used the green-ﬂuorescent JC1
probe that is capable of entering selectively into mitochondria,
and changes reversibly its emission from green to orange with
the increase of membrane potential. The red-to-green ratio of JC1
ﬂuorescence is dependent only on membrane potential and not
on other factors that may inﬂuence single-component ﬂuorescence
signals, such as mitochondrial size, shape and density.
Applying this technique, results of 100 different microscopic
ﬁelds showed that exposure to the metal exerted no signiﬁcant ef-
fect on the variation of mitochondrial membrane potential (Fig. 2).
3.2. Reactive oxygen species
We also determined whether our CdCl2 application doses and
exposure times could induce reactive oxygen species (ROS) pro-een ﬂuorescence of control and Cd-treated MDA-MB231 cells for 24-h and 96-h. The
to CdCl2 exerted no signiﬁcant effect on the variation of mitochondrial membrane
icrographs of control and Cd-treated MDA-MB231 cells stained with APF showing
. (Bottom) Histogram representing the average relative pixel intensity of 50 different
. (Far right) Staining of H2O2-treated MDA-MB231 cells taken as a control.
Fig. 4. Hsp60mRNA expression levels. (Top) Northern blots of total RNA from control and Cd-treated MDA-MB231 cells hybridized with hsp60, hsp70, COXII, COXIV and 18S
probes. (Bottom) Histogram showing the average normalized expression levels of the mRNAs after densitometric analysis of triplicate blots. Bars indicate mean values for
each group of samples. SDs are also indicated. The amount of hsp60 mRNA increased in all the treated samples, except for that obtained after incubation with 5 lM CdCl2 for
24-h; on the other hand, the amount of hsp70 mRNA remained invariant, whilst the amount of COXII and COXIV mRNAs showed no change after 24-h exposure and a
decrease after 96-h exposure (*p 6 0.05).
Fig. 5. Hsp60 protein levels. Western blot of mitochondrial (A, C) or post-mitochondrial (B, D) protein fractions, stained with Ponceau Red (top) or incubated with anti-hsp60
antibody (bottom). The intensity of each band was measured by densitometry and normalized to that of the total amount of loaded proteins. The histograms show the
accumulation levels of hsp60 of six independent experiments after CdCl2 exposure. The amount of hsp60 in M fraction decreased after incubation with 5 lM CdCl2 for 24- or
96-h; whilst it increased at both exposure times when CdCl2 concentration was raised up to 50 lM. In the PM fraction, the protein amount decreased after 24-h exposures
with 5 lM CdCl2 although increased in the other experimental conditions. Bars indicate mean values of six independent experiments for each group of samples. SDs are also
indicated (*p 6 0.05).
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that, whilst no substantial ROS production was detectable in trea-
ted cells after 24-h of incubation with CdCl2, metal exposure for
96-h triggered ﬂuorescence emission, indicative of massive ROS
production, to an extent similar to that of H2O2-treated cells, uti-
lized as controls.
Cumulatively, the data obtained from the ﬁrst group of experi-
ments indicated that mitochondria appear to be a target of CdCl2
after prolonged (96-h) exposure; although no modiﬁcation of the
mitochondrial mass was detectable after all treatments.
Interestingly, cellular respiratory activity appeared to be in-
creased and a signiﬁcant induction of reactive oxygen species
could be concomitantly revealed.3.3. Mitochondrial gene expression
Cells can react to both physical and chemical environmental in-
sults by promoting the heat shock response. The next set of assays
was designed to examine, at a molecular level, the effect exerted by
CdCl2 on the organelles of MDA-MB231 cells, in particular the
expression levels of two mitochondrial heat shock proteins coded
by nuclear genome, i.e. hsp60 and hsp70, whose induction is an
event largely shared by mammalian cells submitted to heat shock
or chemical stresses. We also evaluated the effects exerted by the
metal on the expression of two subunits of the cytochrome oxidase
complex (COX), the terminal component of the mitochondrialFig. 6. Hsc70/hsp70 protein levels. Western blot of post-mitochondrial protein fractions,
(B, D) antibodies (bottom). The histograms show the average normalized accumulation l
amount of hsp70 and hsc70 after 24-h exposure did not change, while it increased after
*p 6 0.05.respiratory chain, i.e. the subunits II (encoded by the mitochondrial
genome) and IV (encoded by a nuclear gene).
We studied hsp60, hsp70, COXII and COXIV expression levels.
Equal amounts of total RNA, puriﬁed from cells after different
CdCl2 exposures, were analyzed by Northern blot assays. As shown
in the panel of Fig. 4, 24-h exposures with 5 lM CdCl2 were able to
promote the down-regulation of hsp60, whereas different degrees
of up-regulation could be observed after 24-h exposures with
50 lM or 96-h exposures with both 5 and 50 lM CdCl2. The expo-
sures to the metal did not appear to modify hsp70 expression. On
the other hand 24-h exposure to the metal did not change COXII
and COXIV expression, while 96-h exposure induced the decrease
of both messengers.
3.4. Mitochondrial protein expression
We then analyzed the effect of CdCl2 exposure on the accumu-
lation of hsp60 protein product by Western blots. As shown in
Fig. 5, hsp60 was recognized by the speciﬁc antibody in both M
and PM protein extracts of control and Cd-treated MDA-MB231
cells. In particular, when the cells were incubated with the metal
at 5 lM CdCl2 for 24- or 96-h, the amount of hsp60 in M fraction
decreased; vice versa, when CdCl2 applied at a dose of 50 lM, the
level of accumulated protein increased at both exposure times
(panels A and C). In the PM fraction, the protein amount decreased
after 24-h exposures with 5 lM CdCl2 although increased at the
other experimental conditions (panels B and D).stained with Ponceau Red (top) or incubated with either anti-hsc70 (A, C) or hsp70
evels of hsc70 and hsp70 of six independent experiments after CdCl2 exposure. The
96-h exposure. Data are represented as means ± SD and signiﬁcance was tested at
Fig. 7. COXII and COXIV protein levels. Western blot of mitochondrial protein fractions stained with Ponceau Red (top) or incubated with either anti-COXII (A, C) or -COXIV (B,
D) antibodies (bottom). The histograms show the average normalized accumulation levels of COXII and COXIV of six independent experiments in the mitochondrial fraction
after CdCl2 exposure. The amount of COXII and COXIV remained constant after 24-h exposure, while it appeared to decrease after 96-h exposure. Data are represented as
means ± SD and signiﬁcance was tested at *p 6 0.05.
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tracts was due to contamination with broken mitochondria, paral-
lel blots were tested with antibodies directed against some
mitochondrial proteins like COXIII and MnSOD (data not shown).
We also evaluated the effects exerted by the heavy metal on the
degree of accumulation of both hsp70 and hsc70 proteins in the PM
fraction. As shown in Fig. 6, the 24-h exposure did not cause any
change in the amount of hsp70 and hsc70 present in the protein
extract (panels A and B), while the 96-h exposure induced a drastic
increase of both stress response proteins (panels C and D).
In the last set of experiments, we analyzed the effect of CdCl2 on
the accumulation of COXIV and COXII proteins in the mitochon-
drial fraction. As shown in the panel of Fig. 7 both COXII and COXIV
were recognized by the speciﬁc antisera only in M extracts from
control and Cd-treated cells. In addition, we found that after 24-
h exposures the levels of COXII and COXIV amounts remained con-
stant (panels A and B), while they appeared to decrease after longer
incubations (96-h) (panels C and D).
4. Discussion
It is widely acknowledged that Cd is able to exert multiple ef-
fects on biological systems, both cytotoxic, which frequently lead
to the production of speciﬁc stress response proteins thereby often
determining the switching-on of apoptotic mechanisms, and carci-
nogenetic, responsible of neoplastic cell transformation (e.g.
[4,8,11]. The complexity and diversity of the molecular eventsunderlying cell–metal interactions are responsible of the data frag-
mentation and poor knowledge of the intracellular pathways in-
volved; nonetheless, signiﬁcant indications are surely emerging
from the evaluation of peculiar aspects of cell metabolism (i.e. gene
expression and protein accumulation/trafﬁc) and of intracellular
oxidative state. Mitochondria are among the key intracellular tar-
gets for different stressors including Cd, but the mechanisms of
metal-induced mitochondrial damage are not fully understood
[45].
In the present study, we incubated ER MDA-MB231 neoplastic
cells, derived from human breast epithelium, to incubation with 5
or 50 lM CdCl2 (similar to levels encountered in occupational or
acute exposure, respectively) for 24- or 96-h time lapses. The via-
bility/proliferative response of these cells in the presence of CdCl2
at different concentration have been already evaluated [25]. Here,
we speciﬁcally focused our analysis on features related to the orga-
nelle function and to the expression, biosynthesis and accumula-
tion of selected mitochondrial components.
4.1. Mitochondria-related activity
In mammals, the regulation of mitochondrial biogenesis re-
quires the coordinated expression of nuclear and mitochondrial
genomes [46] and is inﬂuenced by external factors, such as nutri-
ents, hormones, temperature, exercise, or by hypoxia and aging
[47]. In our model, we have observed that the mitochondrial mass
remained constant under every experimental condition utilized,
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chondrial proliferation. Interestingly, the 96-h exposure induced a
signiﬁcant increase of respiratory activity even in the absence of
variations of mitochondrial membrane potential. This result sug-
gests that CdCl2 induced an increased rate of respiration when
accumulated in MDA-MB231 cells. In different tissues, in fact, Cd
was proven to affect the activity of complexes II and III of the elec-
tron transfer chain, also depleting glutathione and other free radi-
cal scavengers, thereby generating respiratory dysfunctions and
production of ROS, and, in some cases, inducing some of the known
variants of apoptosis death [48–50]. An equivalent oxidative dam-
age was also reported recently for Cd-intoxicated plant cells indi-
cating that such Cd-dependent effect is shared by different model
systems [51].
Concerning ROS production by mitochondria [4,8], our results
showed that only the 96-h exposure with CdCl2 induced a massive
accumulation of these reactive species, even in the absence of
changes of transmembrane potential. Noteworthy, in marine inver-
tebrates Cd-triggered apoptosis can take place in the absence of
signiﬁcant alterations of mitochondrial membrane permeability
[52]. On the other hand, the prolonged production of ROS can cause
the disruption of the mitochondrial electron transport and strongly
interfere with mitochondrial permeability transition pores, as re-
ported in other model systems [48,50]. Interestingly, Rip-1, mem-
ber of a kinase family acting as sensor of cellular stress and crucial
regulator of cell viability [53], whose gene expression is promi-
nently switched-on after CdCl2 exposure of MDA-MB231 cells
[25], is known to be involved in ROS formation by activation of
cytosolic phospholipase A2 and/or enhanced electron ﬂow through
the mitochondrial electron transport chain [54]. It remains to be
elucidated whether Rip-1 up-regulation is responsible of ROS accu-
mulation in MDA-MB231 following CdCl2 exposure. Moreover,
Dorta et al. [55], proposed a sequence of events accounting for
Cd-induced mitochondrial impairment in normal rat liver mito-
chondria, beginning with an apparent interaction of the metal with
speciﬁc protein thiols in the mitochondrial membrane, resulting in
the onset of mitochondrial permeability transition (MPT) and in
the dissipation of the transmembrane electrical potential.
4.2. Mitochondrial gene expression
Some of us demonstrated that CdCl2 administration to tumor
and immortalized breast cells generated a very different pattern
of gene expression [25]; dealing with MDA-MB231 cells, in partic-
ular the metal also promoted a massive transcriptional activation
of Dap kinase and of six different caspases, whilst down-regulated
grp78 and Bcl-2. In the present work, we have expanded the list
of Cd-responsive genes by demonstrating that selected concentra-
tions and duration times of CdCl2 exposure are active in modifying
hsp60 expression levels; in particular, 24-h exposition to 5 lM
CdCl2 resulted in hsp60 down-regulation, whereas up-regulation
was attained by increasing metal concentration up to 50 lM for
both exposure periods. The induction of hsp60 would be expected
to provide assistance to the cell in the refolding and processing of
damaged proteins or, as recent ﬁndings also suggest in the regula-
tion of programmed cell death [56]. The over-expression of hsp
chaperones can depend on Cd-promoted denaturation and oxida-
tion of proteins, and is probably linked to the increase of oxidative
stress. Although hsp60 is mostly localized in the mitochondrial
matrix, it has also been found in other subcellular localizations
including the ER, cell surface, and unidentiﬁed vesicles and cyto-
plasmic granules [57] and also found to be over-expressed and
localized in the cytoplasm of cancer cells [58]. In the current study,
we report the presence of hsp60 in the cytoplasm of MDA-MB231
tumor cells and demonstrate that CdCl2 exposure modiﬁes the
cytosolic level of the protein. In particular, we revealed a decreaseof the protein amount in PM fractions after 24-h exposure to 5 lM
CdCl2, in contrast to the other experimental conditions where the
content of hsp60 was found to be increased. In the light of the data
obtained from 96-h exposure to 5 lM CdCl2, demonstrating the in-
crease of hsp60 expression level, the decrease of protein amount in
the mitochondria and, conversely, its increase in the PM fraction,
we can tentatively hypothesize an impairing effect on both biosyn-
thetic and import processes, resulting in the accumulation of the
chaperonine in the cytoplasm. The mechanism by which hsp60 is
retained or sequestered in the cytoplasm is not known yet, and
warrants further studies.
In response to environmental stresses, the gene coding for the
inducible 70 kDa heat shock protein (hsp70) is rapidly activated.
Hsp70 prevents the incorrect folding and assembly of peptides,
avoids the transport of misfolded or degraded proteins, preparing
them to elimination, and inhibits the induction of apoptosis [59].
Hsp70 functions as part of multi-component chaperone machinery
in living cells, and its activity is modulated by different sets of
cofactors [60]. In A549 human pulmonary cells line, the hsp72 pro-
tein was over-expressed under stressing conditions, following
short-term exposure (2–6 h) to Cd doses higher than 50 lM, or
doses as low as 0.1–1 lM for exposures lasting longer than 48 h,
thereby being considered an early biomarker of short-term expo-
sure [61]. Here, we analyzed the expression levels of inducible
hsp70 and also of hsc70, its constitutive form, and we found that
in MDA-MB231 cells, only the 96-h exposure induced the over-
expression of the two proteins. Moreover, we noticed that the rel-
ative concentration of hsp70 mRNA remained constant under
every experimental conditions. It is known that the control of the
oxidative phosphorylation mainly relies on the terminal compo-
nent of the respiratory chain, i.e. the cytochrome c oxidase com-
plex (COX), which catalyzes the transfer of electrons from
cytochrome c to molecular oxygen. So far, the effect of CdCl2 on
the expression of the genes coding for COX subunits has been
poorly investigated, except for a single paper suggesting that in
some mollusc species COXI gene is up-regulated after metal con-
tamination [62]. We therefore studied the expression of some sub-
units of this complex in our experimental model system and we
found that the levels of COXII and COXIV mRNAs and proteins re-
mained constant after 24-h exposure, while they decreased after
longer incubations (96-h). It is noteworthy that the lack of physio-
logic amounts of some COX subunits did not inﬂuence the mito-
chondrial energetic rate, however, it must be taken into account
that in all tissues studied, the enzyme content was in a large excess
compared with what is required for state 3 respiration [63]. Hypo-
thetically, the reduction of the amount of COX subunits could be
related to ROS production since mitochondrial proteins are often
among the ﬁrst targets of ROS attack in cells because of their
immediate proximity to the ROS-generating sources [64].
Taken together, our results suggest that mitochondria can be
considered as a target of CdCl2 after exposure of ER MDA-
MB231 cell line for periods as long as 96-h. In addition the present
data provide additional indications that this cell line can be consid-
ered a suitable in vitromodel for further studies of the intracellular
molecular mechanisms of death response induced by Cd intoxica-
tion in human tumor cells.
5. Abbreviations
Cd cadmium
ER estrogens receptor-negative
ROS reactive oxygen species
HB homogenization buffer
EGTA ethylene glycol tetraacetic acid
CAPS cyclohexylamino-1-propanesulfonic acid
MPT mitochondrial permeability transition
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